Member Info for J427

Oh dear, someone has not been doing his home work.
CF is very clear on his presentations on the cash status of the company and even talks of paying out a div.
I like others think I would like the cash to be ploughed back into the company for growth.

I think it's at the bottom IMO . News on vaccine approval should be reported on 28th/29th Dec.
Bought in this morning at this price.

With the pending news "data expected to be available before the end of 2020." following the Brazil trial we could have an early Christmas present. They might release some data stating the indicators and await a full report at a later date in the New Year. I cannot see them holding back on the good news.
L2 are lining up to pile in as they know the news will land soon. IMO

https://news.sky.com/story/covid-19-chaotic-start-for-testing-scheme-designed-to-cut-quarantine-12163059

Sky News just reported shortage and problems of rapid testing at Heathrow and government looking at adding big companies to testing list.

This is great news and with the USA market being massive the sales potential is massive . USA are in big trouble with covid and they are ramping testing . Moving north and big top up.

Smithy You on the right board?

10m Trade at the end of the day. Showing as a buy. Pushed the share price up.

Bit of confusion on the time posting 1 hour to go. The Corporate Update Call Presentation is @21.15 GMT tonight 2/12/20 ( 16:15 ET time )
Interesting to hear the updates.

Australia Stock Exchange is open until:

Wed, Dec 2, 16:00 +11:00

We will get news tomorrow ( Oz time difference ?) hopefully we will have had the funding all sorted and moving on up. The funding might be 10% which will not have an impact but anything a lot larger then a reassessment on the SP against MCAP.
Once we get the news I see us going north all the way until Q1 2021 then the SP @24 will look like a bargain.
I see this as a temporary funding to cover the stop gap. We end up with more cash on the balance sheet at the end.

I will be in once I see it steady and bottom around 24p is good support at the moment with some buying support .

I was still looking at topping up and see this as an opportunity. The fundamentals have not changed for me and I see upside once the dust settles. End of Q1 is still a big mile stone in my calendar for this company. Black Friady bargain might be here for the pickings.

What do we think the upshot of the RNS suspension on the SP today.

The lock down is obviously affecting peoples discussions. The fundamentals of this company have not changed. We have excellent tech and soon to be launched which will take the market by storm. It's easy if you are impatient and sell out missing the launch it's up to you. FOMO stay invested.

FOMO if a later RNS lands . Speculation or real news is just around the corner than is the question.. Why be out ?

trilla1337 Yes I know AVCT aren't in the RCT right. That's why I said "we" as in ODX in the RTC which is this board . May be you took it as I posted it in the Avacta heading HAHA

We are in on the RTC so if news drops tomorrow this looks a bargain.

DB explain India ICRM supply of testing incomparable using automated extraction. Package inserts had to be changed then resubmitted and no communication for over two months really disappointing.
Now in November full engaged and expect approval in very very near future for all three kits and Genedrive exporter software. Taken from the presentation.

Will sell in US without Beckman which means we are not tied. Great news. Sell without FDA approval another chestnut.

Very slick presentation with lots of facts and the pipeline slide 0-6 months short term looks like all good news.
I have come away with a very positive outlook.